Literature DB >> 26477364

Regulation and Evolution of the RAG Recombinase.

Grace Teng1, David G Schatz2.   

Abstract

The modular, noncontiguous architecture of the antigen receptor genes necessitates their assembly through V(D)J recombination. This program of DNA breakage and rejoining occurs during early lymphocyte development, and depends on the RAG1 and RAG2 proteins, whose collaborative endonuclease activity targets specific DNA motifs enriched in the antigen receptor loci. This essential gene shuffling reaction requires lymphocytes to traverse several developmental stages wherein DNA breakage is tolerated, while minimizing the expense to overall genome integrity. Thus, RAG activity is subject to stringent temporal and spatial regulation. The RAG proteins themselves also contribute autoregulatory properties that coordinate their DNA cleavage activity with target chromatin structure, cell cycle status, and DNA repair pathways. Even so, lapses in regulatory restriction of RAG activity are apparent in the aberrant V(D)J recombination events that underlie many lymphomas. In this review, we discuss the current understanding of the RAG endonuclease, its widespread binding in the lymphocyte genome, its noncleavage activities that restrain its enzymatic potential, and the growing evidence of its evolution from an ancient transposase.
© 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adaptive immunity; Cryptic RSS; Genome instability; RAG1; RAG2; Transposon; V(D)J recombination

Mesh:

Substances:

Year:  2015        PMID: 26477364     DOI: 10.1016/bs.ai.2015.07.002

Source DB:  PubMed          Journal:  Adv Immunol        ISSN: 0065-2776            Impact factor:   3.543


  32 in total

1.  Intra-Vκ Cluster Recombination Shapes the Ig Kappa Locus Repertoire.

Authors:  Kenta Shinoda; Yaakov Maman; Andres Canela; David G Schatz; Ferenc Livak; André Nussenzweig
Journal:  Cell Rep       Date:  2019-12-24       Impact factor: 9.423

2.  The RAG transposon is active through the deuterostome evolution and domesticated in jawed vertebrates.

Authors:  Jose Ricardo Morales Poole; Sheng Feng Huang; Anlong Xu; Justine Bayet; Pierre Pontarotti
Journal:  Immunogenetics       Date:  2017-04-28       Impact factor: 2.846

Review 3.  RAG gene defects at the verge of immunodeficiency and immune dysregulation.

Authors:  Anna Villa; Luigi D Notarangelo
Journal:  Immunol Rev       Date:  2019-01       Impact factor: 12.988

4.  Epigenetic modifications of the VH region after DJH recombination in Pro-B cells.

Authors:  Yanying Dong; Caijun Wu; Xiaohui Zhao; Ping Zhang; Hua Zhang; Mingzhe Zheng; Shichang Li; Junna Jiao; Xiaozhuo Yu; Zhuangwei Lv; Yanhong Ji
Journal:  Immunology       Date:  2017-06-23       Impact factor: 7.397

5.  Highly sensitive and unbiased approach for elucidating antibody repertoires.

Authors:  Sherry G Lin; Zhaoqing Ba; Zhou Du; Yu Zhang; Jiazhi Hu; Frederick W Alt
Journal:  Proc Natl Acad Sci U S A       Date:  2016-06-27       Impact factor: 11.205

Review 6.  V(D)J recombination, somatic hypermutation and class switch recombination of immunoglobulins: mechanism and regulation.

Authors:  Xiying Chi; Yue Li; Xiaoyan Qiu
Journal:  Immunology       Date:  2020-02-27       Impact factor: 7.397

7.  Nbn-Mre11 interaction is required for tumor suppression and genomic integrity.

Authors:  Jun Hyun Kim; Alexander V Penson; Barry S Taylor; John H J Petrini
Journal:  Proc Natl Acad Sci U S A       Date:  2019-07-08       Impact factor: 11.205

Review 8.  The recent advances in non-homologous end-joining through the lens of lymphocyte development.

Authors:  Xiaobin S Wang; Brian J Lee; Shan Zha
Journal:  DNA Repair (Amst)       Date:  2020-06-25

Review 9.  Riches in RAGs: Revealing the V(D)J Recombinase through High-Resolution Structures.

Authors:  Karla K Rodgers
Journal:  Trends Biochem Sci       Date:  2016-11-05       Impact factor: 13.807

Review 10.  Genetics of Cutaneous T Cell Lymphoma: From Bench to Bedside.

Authors:  William E Damsky; Jaehyuk Choi
Journal:  Curr Treat Options Oncol       Date:  2016-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.